Featured Research

from universities, journals, and other organizations

New medications faster: Harvesting biomolecules more quickly and reliably

Date:
April 11, 2010
Source:
Fraunhofer-Gesellschaft
Summary:
Before a new medication arrives on the market, it must be tested on animal models and in humans. In order to conduct these tests, a substantial amount of the therapeutically effective substances are needed -- such as proteins or nucleic acids, for example. Researchers in Germany are now presenting several processes with which biomolecules can be harvested quickly, robustly, reliably and with versatility.

Before a new medication arrives on the market, it must be tested on animal models and in humans. In order to conduct these tests, a substantial amount of the therapeutically effective substances are needed -- such as proteins or nucleic acids, for example. At the BIO International Convention 2010 in Chicago from May 3 to 6, Fraunhofer researchers will present several processes with which biomolecules can be harvested quickly, robustly, reliably and with versatility -- and all processes comply with the GMP standard.

Biomolecules are medicine's jacks-of-all-trades: They are suitable for the diagnosis and treatment of cancer diseases; they are used in the treatment of multiple sclerosis and asthma; they help stimulate the build-up of the body's own immune defenses with flu and polio inoculations. In the laboratories of the pharmaceutical industry, new biomolecules are constantly being engineered: Specific antibodies, customized proteins and nucleic acids -- the core components of genetic material -- are considered promising candidates for therapeutic approaches.

"Medical-pharmacological research will soon be using more biomolecules than ever before. Processes will be increasingly needed with which these biomolecules can be produced rapidly, in sufficient quantities and of clinically quality," says Dr. Holger Ziehr, who heads the pharmaceutical biotechnology department of the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM at its Braunschweig site. "Our new platform technologies meet these performance capabilities: We can synthesize nearly any antibody, protein or nucleic acid in cell cultures -- irrespective of their binding properties and base sequences." The systems for producing customized biomolecules meet the "Good Manufacturing Practice" -"GMP" -- quality standard of the European Medicines Agency EMA as well as the USA's Food and Drug Administration FDA.

For the production of the various classes of biomolecules, the researchers at ITEM are working closely with the Fraunhofer USA Center for Molecular Biotechnology CMB in Newark, Delaware. Three production systems in total are operated at both sites: In Braunschweig, there are bioreactors that produce antibodies in transgenic cells -- here they use CHO cells, the cells from hamster ovaries that are commonly deployed in cell research. In addition, the intestinal bacteria E. coli are used for harvesting any nucleic acids. The Delaware-based specialists are able to produce proteins or peptides in plants using "molecular farming." The plants for this are infected with a virus non-toxic to humans that contains the genetic template for the synthesis of the desired biomolecule.

"The Fraunhofer GMP platform technologies are not only extraordinarily versatile for this, they also help save a lot of time in the production and development of candidates for biopharmaceutical substances," explains Ziehr. "We can offer industry customers our full expertise -- from the production of tailored biomolecules to preclinical tests based on 'Good Laboratory Practice' -- 'GLP' -- through to clinical investigations per the GCP or 'Good Clinical Practice' standard. Outside of the major pharmaceutical corporations in Germany, there is nothing else like this except at the Fraunhofer-Group for Life Sciences."


Story Source:

The above story is based on materials provided by Fraunhofer-Gesellschaft. Note: Materials may be edited for content and length.


Cite This Page:

Fraunhofer-Gesellschaft. "New medications faster: Harvesting biomolecules more quickly and reliably." ScienceDaily. ScienceDaily, 11 April 2010. <www.sciencedaily.com/releases/2010/04/100408095502.htm>.
Fraunhofer-Gesellschaft. (2010, April 11). New medications faster: Harvesting biomolecules more quickly and reliably. ScienceDaily. Retrieved April 20, 2014 from www.sciencedaily.com/releases/2010/04/100408095502.htm
Fraunhofer-Gesellschaft. "New medications faster: Harvesting biomolecules more quickly and reliably." ScienceDaily. www.sciencedaily.com/releases/2010/04/100408095502.htm (accessed April 20, 2014).

Share This



More Matter & Energy News

Sunday, April 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Why Did Nike Fire Most Of Its Nike FuelBand Team?

Why Did Nike Fire Most Of Its Nike FuelBand Team?

Newsy (Apr. 19, 2014) Nike fired most of its Digital Sport hardware team, the group behind Nike's FuelBand device. Could Apple or an overcrowded market be behind layoffs? Video provided by Newsy
Powered by NewsLook.com
Small Reactors Could Be Future of Nuclear Energy

Small Reactors Could Be Future of Nuclear Energy

AP (Apr. 17, 2014) After the Fukushima nuclear disaster, the industry fell under intense scrutiny. Now, small underground nuclear power plants are being considered as the possible future of the nuclear energy. (April 17) Video provided by AP
Powered by NewsLook.com
Horseless Carriage Introduced at NY Auto Show

Horseless Carriage Introduced at NY Auto Show

AP (Apr. 17, 2014) An electric car that proponents hope will replace horse-drawn carriages in New York City has also been revealed at the auto show. (Apr. 17) Video provided by AP
Powered by NewsLook.com
Honda's New ASIMO Robot, More Human-Like Than Ever

Honda's New ASIMO Robot, More Human-Like Than Ever

AFP (Apr. 17, 2014) It walks and runs, even up and down stairs. It can open a bottle and serve a drink, and politely tries to shake hands with a stranger. Meet the latest ASIMO, Honda's humanoid robot. Duration: 00:54 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins